Despite near-term woes, Demant is a good bet
03/12/25 -"Despite challenges that have reduced our target price, Demant still presents a significant upside. The company is poised to benefit from: 1) new product launches; 2) exiting the Hearing Implants ..."
Pages
63
Language
English
Published on
03/12/25
You may also be interested by these reports :
03/12/25
Despite challenges that have reduced our target price, Demant still presents a significant upside. The company is poised to benefit from: 1) new ...
27/11/25
We have lowered our target price to reflect the business challenges outlined in the EPS section. Additionally, we have adjusted the peer-based ...
26/11/25
While Q2 sales slightly missed market expectations, Elekta’s Q2 profitability surpassed forecasts, despite tariff impacts and FX headwinds. Improved ...
14/11/25
Sonova reported decent H1 results, with sales aligning with the company-compiled consensus. However, normalised EBITA did not meet expectations due ...